The linearity of the effect of the PSA slope on prostate cancer risk was confirmed in the present study, showing an increased risk of prostate cancer for PSA slopes ranging between 0.5 and 3.5 ng/mL/year. This evidence concerns the gene KLK3 and prostate carcinoma.